相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease A Truncated Randomized Phase 2b/3 Clinical Trial
Reisa Sperling et al.
JAMA NEUROLOGY (2021)
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
Guenter U. Hoeglinger et al.
LANCET NEUROLOGY (2021)
Donanemab in Early Alzheimer's Disease
Mark A. Mintun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis
Sarah F. Ackley et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Questions EMERGE as Biogen claims aducanumab turnaround
Robert Howard et al.
NATURE REVIEWS NEUROLOGY (2020)
The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up
Goril Rolfseng Grontvedt et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
A resurrection of aducanumab for Alzheimer's disease
Lon Schneider
LANCET NEUROLOGY (2020)
Amyloid β-protein and beyond: the path forward in Alzheimer's disease
Dominic M. Walsh et al.
CURRENT OPINION IN NEUROBIOLOGY (2020)
Kinetic diversity of amyloid oligomers
Alexander J. Dear et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology
Maja Malmberg et al.
FRONTIERS IN NEUROSCIENCE (2020)
A 3D human brain-like tissue model of herpes-induced Alzheimer's disease
Dana M. Cairns et al.
SCIENCE ADVANCES (2020)
The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics
Sarah A. Kent et al.
ACTA NEUROPATHOLOGICA (2020)
Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Kevin Mullane et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Shifts and drifts in prion science
Adriano Aguzzi et al.
SCIENCE (2020)
The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies
Eider M. Arenaza-Urquijo et al.
BRAIN (2019)
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
Alberto J. Espay et al.
NEUROLOGY (2019)
The viral protein corona directs viral pathogenesis and amyloid aggregation
Kariem Ezzat et al.
NATURE COMMUNICATIONS (2019)
Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework
Clifford R. Jack et al.
JAMA NEUROLOGY (2019)
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
J. Scott Andrews et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes
Johnny Habchi et al.
NATURE CHEMISTRY (2018)
ABBY A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease
Jeffrey L. Cummings et al.
NEUROLOGY (2018)
Memory decline accompanies subthreshold amyloid accumulation
Susan M. Landau et al.
NEUROLOGY (2018)
Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan
Nian-Sheng Tzeng et al.
NEUROTHERAPEUTICS (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Eric McDade et al.
NEUROLOGY (2018)
The antimicrobial protection hypothesis of Alzheimer's disease
Robert D. Moir et al.
ALZHEIMERS & DEMENTIA (2018)
Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults
Michelle E. Farrell et al.
NEUROLOGY (2018)
Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
Michael C. Donohue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα
Bruce G. Mockett et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Structural Studies of Amyloid Proteins at the Molecular Level
David S. Eisenberg et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 86 (2017)
Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model
Romain Fol et al.
ACTA NEUROPATHOLOGICA (2016)
Immunotherapies in Alzheimer's disease: Too much, too little, too late or off-target?
Isabelle St-Amour et al.
ACTA NEUROPATHOLOGICA (2016)
Alzheimer disease: modeling an Aβ-centered biological network
D. Campion et al.
MOLECULAR PSYCHIATRY (2016)
The activities of amyloids from a structural perspective
Roland Riek et al.
NATURE (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
In vivo aspects of protein folding and quality control
David Balchin et al.
SCIENCE (2016)
Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease
Deepak Kumar Vijaya Kumar et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The Neuropathology of Chronic Traumatic Encephalopathy
Ann C. McKee et al.
BRAIN PATHOLOGY (2015)
Role of Amylin in Type 1 and Type 2 Diabetes
Laura Hieronymus et al.
DIABETES EDUCATOR (2015)
The association between infectious burden and Parkinson's disease: A case-control study
Xian-Le Bu et al.
PARKINSONISM & RELATED DISORDERS (2015)
Monomeric β-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons
Maria L. Giuffrida et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease
Wesley Jongbloed et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
Altered Cerebrospinal Fluid Levels of Amyloid β and Amyloid Precursor-Like Protein 1 Peptides in Down's Syndrome
Erik Portelius et al.
NEUROMOLECULAR MEDICINE (2014)
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
Argonde C. van Harten et al.
ALZHEIMERS & DEMENTIA (2013)
Effect of Proline Mutations on the Monomer Conformations of Amylin
Chi-cheng Chiu et al.
BIOPHYSICAL JOURNAL (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients
Giulia M. Sancesario et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia
Archana B. Balasubramanian et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Amyloid-β Associated Volume Loss Occurs Only in the Presence of Phospho-Tau
Rahul S. Desikan et al.
ANNALS OF NEUROLOGY (2011)
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
Prashanthi Vemuri et al.
BRAIN (2011)
Neuronal activity regulates the regional vulnerability to amyloid-β deposition
Adam W. Bero et al.
NATURE NEUROSCIENCE (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
β-Amyloid Monomers Are Neuroprotective
Maria Laura Giuffrida et al.
JOURNAL OF NEUROSCIENCE (2009)
APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old
Daniel J. Berlau et al.
NEUROLOGY (2009)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis
CG Glabe et al.
NEUROLOGY (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory
RL Buckner et al.
JOURNAL OF NEUROSCIENCE (2005)
Herpesviruses in brains in Alzheimer's and Parkinson's diseases
N Hemling et al.
ANNALS OF NEUROLOGY (2003)
Distinguishing between neurodegenerative disease and disease-free aging: Correlating neuropsychological evaluations and neuropathological studies in centenarians
MH Silver et al.
PSYCHOSOMATIC MEDICINE (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Prevalence of Alzheimer's disease in very elderly people -: A prospective neuropathological study
T Polvikoski et al.
NEUROLOGY (2001)
分享论文
